29 Patents
- US125891142026GABA Agonists and Antagonists Affect Differentiation of Hematopoietic Stem Cells and Megakaryocyte Progenitors
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US124102592025CD47 Targeted Therapies for the Treatment of Infectious Disease
The Regents Of The University Of California
0 cites - US123702432025Non-genotoxic Conditioning Regimen for Stem Cell Transplantation
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US123184482025Use of TLR Agonist and Anti-cd47 Agent to Enhance Phagocytosis of Cancer Cells
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US122747462025Dosing Parameters for CD47 Targeting Therapies to Hematologic Malignancies
Forty Seven, LLC
0 cites - US122583992025Methods for Achieving Therapeutically Effective Doses of Anti-cd47 Agents
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US122584032025Methods for Treating Myeloma by Achieving Therapeutically Effective Doses of Anti-cd47 Antibody
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US122330932025Engraftment of Stem Cells with a Combination of an Agent That Targets Stem Cells and Modulation of Immunoregulatory Signaling
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US121940932025Dosing Parameters for CD47 Targeting Therapies to Hematologic Malignancies
Forty Seven, LLC
0 cites - US121955322025High Affinity Sirp-alpha Reagents and Methods of Using
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US121629392024Methods for Manipulating Phagocytosis Mediated by CD47
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US120914562024Targeting Aneurysm Disease by Modulating Phagocytosis Pathways
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US120374022024Treatment of Cancer with Dual Targeting of CD47 and EGFR
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US120309442024Enhanced Depletion of Targeted Cells with CD47 Blockade and an Immune Costimulatory Agonist
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US119650342024Antifibrotic Activity of CD47 Blockade in the Liver
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US119053332024Selective Immunodepletion of Endogenous Stem Cell Niche for Engraftment
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US118144192023High Affinity PD-1 Agents and Methods of Use
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US118076842023Humanized and Chimeric Monoclonal Antibodies to CD47
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US117809182023Markers of Acute Myeloid Leukemia Stem Cells
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US117809312023CD47 Targeted Therapies for the Treatment of Infectious Disease
The Regents Of The University Of California
0 cites - US117731652023Markers of Acute Myeloid Leukemia Stem Cells
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US117664542023Use of TLR Agonist and Anti-cd47 Agent to Enhance Phagocytosis of Cancer Cells
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US117608002023Markers of Acute Myeloid Leukemia Stem Cells
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US117608102023Modified Immunoglobulin Hinge Regions to Reduce Hemagglutination
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US117186702023Methods for Determining and Achieving Therapeutically Effective Doses of Anti-cd47 Agents in Treatment of Cancer
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US117186752023Disrupting FC Receptor Engagement on Macrophages Enhances Efficacy of Anti-sirpalpha Antibody Therapy
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - 0 cites
- US116083772023Enhanced Depletion of Targeted Cells with CD47 Blockade and an Immune Costimulatory Agonist
The Board Of Trustees Of The Leland Stanford Junior University
0 cites - US116034042023Methods for Treating Cancer by Achieving Therapeutically Effective Doses of Anti-cd47 Antibody
The Board Of Trustees Of The Leland Stanford Junior University
0 cites